Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Biotech
Spruce’s successful FDA talks plant seeds for Q4 filing
Spruce took another step toward filing for FDA approval, ticking off some of the manufacturing tasks needed to submit the long-awaited application.
Nick Paul Taylor
Aug 24, 2026 9:57am
Amylyx GLP-1 inhibitor halves blood sugar crashes in ph. 3 win
Aug 18, 2026 7:01am
Leo's $435M deal for Tanabe skin disease drug awaiting FDA nod
Aug 18, 2026 3:00am
Zydus’ Sentynl pens $475M deal for Mereo's rare lung disease drug
Aug 11, 2026 10:20am
Ensoma sheds more staff, pauses preclinical programs
Aug 7, 2026 11:16am
BioMarin axes $270M asset after missing phase 3 endpoint
Aug 7, 2026 9:10am
